These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

649 related articles for article (PubMed ID: 26383234)

  • 41. Current status in cancer cell reprogramming and its clinical implications.
    Izgi K; Canatan H; Iskender B
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):371-383. PubMed ID: 27620745
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epigenetic regulation leading to induced pluripotency drives cancer development in vivo.
    Ohnishi K; Semi K; Yamada Y
    Biochem Biophys Res Commun; 2014 Dec; 455(1-2):10-5. PubMed ID: 25019993
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The transcription factor code in iPSC reprogramming.
    Deng W; Jacobson EC; Collier AJ; Plath K
    Curr Opin Genet Dev; 2021 Oct; 70():89-96. PubMed ID: 34246082
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reprogramming of endometrial adult stromal cells in the presence of a ROCK inhibitor, thiazovivin, could obtain more efficient iPSCs.
    Mohseni R; Shoae-Hassani A; Verdi J
    Cell Biol Int; 2015 May; 39(5):515-8. PubMed ID: 25490878
    [TBL] [Abstract][Full Text] [Related]  

  • 45. New windows to enhance direct reprogramming of somatic cells towards induced pluripotent stem cells.
    Nakhaei-Rad S; Bahrami AR; Mirahmadi M; Matin MM
    Biochem Cell Biol; 2012 Apr; 90(2):115-23. PubMed ID: 22166043
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhancing Induced Pluripotent Stem Cell Generation by MicroRNA.
    Dang J; Rana TM
    Methods Mol Biol; 2016; 1357():71-84. PubMed ID: 25687299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-Mediated Reprogramming of Somatic Cells into Induced Pluripotent Stem Cells.
    Sandmaier SE; Telugu BP
    Methods Mol Biol; 2015; 1330():29-36. PubMed ID: 26621586
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Obstacles to Clinical Translation of iPSCs.
    Tapia N; Schöler HR
    Cell Stem Cell; 2016 Sep; 19(3):298-309. PubMed ID: 27452174
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concise Review: Reprogramming, Behind the Scenes: Noncanonical Neural Stem Cell Signaling Pathways Reveal New, Unseen Regulators of Tissue Plasticity With Therapeutic Implications.
    Poser SW; Chenoweth JG; Colantuoni C; Masjkur J; Chrousos G; Bornstein SR; McKay RD; Androutsellis-Theotokis A
    Stem Cells Transl Med; 2015 Nov; 4(11):1251-7. PubMed ID: 26371344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
    Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
    Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simple and versatile synthetic polydopamine-based surface supports reprogramming of human somatic cells and long-term self-renewal of human pluripotent stem cells under defined conditions.
    Zhou P; Wu F; Zhou T; Cai X; Zhang S; Zhang X; Li Q; Li Y; Zheng Y; Wang M; Lan F; Pan G; Pei D; Wei S
    Biomaterials; 2016 May; 87():1-17. PubMed ID: 26897536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Understanding the molecular mechanisms of reprogramming.
    Krause MN; Sancho-Martinez I; Izpisua Belmonte JC
    Biochem Biophys Res Commun; 2016 May; 473(3):693-7. PubMed ID: 26655812
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Unique molecular events during reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) at naïve state.
    Wang Y; Zhao C; Hou Z; Yang Y; Bi Y; Wang H; Zhang Y; Gao S
    Elife; 2018 Jan; 7():. PubMed ID: 29381138
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nuclear Reprogramming by Defined Factors: Quantity Versus Quality.
    Sebban S; Buganim Y
    Trends Cell Biol; 2016 Jan; 26(1):65-75. PubMed ID: 26437595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cellular Reprogramming Using Protein and Cell-Penetrating Peptides.
    Seo BJ; Hong YJ; Do JT
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273812
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: evidence and implications.
    Firas J; Liu X; Polo JM
    Differentiation; 2014 Jul; 88(1):29-32. PubMed ID: 25281282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Investigating pediatric disorders with induced pluripotent stem cells.
    Durbin MD; Cadar AG; Chun YW; Hong CC
    Pediatr Res; 2018 Oct; 84(4):499-508. PubMed ID: 30065271
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cellular reprogramming: A new way to understand aging mechanisms.
    Yener Ilce B; Cagin U; Yilmazer A
    Wiley Interdiscip Rev Dev Biol; 2018 Mar; 7(2):. PubMed ID: 29350802
    [TBL] [Abstract][Full Text] [Related]  

  • 59. iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?
    Scesa G; Adami R; Bottai D
    Cells; 2021 Jun; 10(6):. PubMed ID: 34208270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reprogramming cancer cells: overview & current progress.
    Lim KL; Teoh HK; Choong PF; Teh HX; Cheong SK; Kamarul T
    Expert Opin Biol Ther; 2016 Jul; 16(7):941-51. PubMed ID: 27070264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.